Kenneth J Winters Selected Research

Hemorrhage

1/2017	Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.
9/2016	Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.
2/2016	Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
1/2016	Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients.
8/2013	Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.
8/2013	Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial.
8/2013	Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients.
6/2013	A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivity.
11/2012	Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trial.
10/2012	Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth J Winters Research Topics

Disease

25	Acute Coronary Syndrome 07/2017 - 10/2006
19	Hemorrhage 01/2017 - 06/2005
16	Coronary Artery Disease (Coronary Atherosclerosis) 09/2014 - 05/2006
12	Myocardial Infarction 07/2017 - 06/2005
8	Stroke (Strokes) 04/2016 - 02/2012
7	Body Weight (Weight, Body) 09/2014 - 12/2008
6	Sickle Cell Anemia (Hemoglobin S Disease) 02/2016 - 02/2013
4	Unstable Angina 01/2017 - 10/2006
4	Thrombosis (Thrombus) 01/2015 - 06/2005
3	ST Elevation Myocardial Infarction 01/2017 - 10/2006
2	Diabetes Mellitus 06/2017 - 03/2016
2	Non-ST Elevated Myocardial Infarction 01/2017 - 03/2016
2	Pain (Aches) 02/2016 - 02/2013
2	Coronary Disease (Coronary Heart Disease) 08/2013 - 06/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2007 - 06/2005
1	Peptic Ulcer (Peptic Ulcers) 01/2017
1	Atrial Fibrillation 09/2016
1	Ischemic Stroke 04/2016
1	Thalassemia 02/2016
1	Neoplasms (Cancer) 01/2016
1	Heart Failure 10/2012
1	Death (Near-Death Experience) 02/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2010
1	Ischemia 06/2005

Drug/Important Bio-Agent (IBA)

42	Prasugrel Hydrochloride FDA Link 06/2017 - 06/2005
34	Clopidogrel (Plavix)FDA Link 06/2017 - 06/2005
19	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2017 - 05/2006
5	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 06/2017 - 01/2015
4	thienopyridineIBA 04/2017 - 08/2008
4	Cytochrome P-450 CYP2C19IBA 03/2016 - 07/2009
3	Biomarkers (Surrogate Marker)IBA 07/2017 - 02/2013
3	Adenosine Diphosphate (ADP)IBA 04/2017 - 02/2014
3	Pharmaceutical PreparationsIBA 01/2016 - 04/2007
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2013 - 08/2008
2	Purinergic P2Y Receptor AntagonistsIBA 04/2017 - 02/2014
2	CreatinineIBA 01/2017 - 03/2016
2	ThienopyridinesIBA 09/2014 - 08/2010
1	pro-brain natriuretic peptide (1-76)IBA 07/2017
1	antineoplaston A10 (A 10)IBA 07/2017
1	C-Reactive ProteinIBA 07/2017
1	HDL CholesterolIBA 06/2016
1	Sickle HemoglobinIBA 02/2016
1	Hemoglobins (Hemoglobin)IBA 02/2016
1	Proton Pump InhibitorsIBA 10/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015
1	Warfarin (Coumadin)FDA LinkGeneric 12/2010
1	Glycoproteins (Glycoprotein)IBA 08/2010
1	Ticlopidine (Ticlid)FDA LinkGeneric 01/2007

Therapy/Procedure

9	Percutaneous Coronary Intervention 06/2017 - 06/2005
9	Therapeutics 06/2017 - 08/2013
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2017 - 10/2006
2	Stents 01/2015 - 02/2012
1	Aftercare (After-Treatment) 01/2010